换一批Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
第一作者：
Kate,Lawrenson
第一单位：
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, USA; Center for Bioinformatics and Functional Genomics, Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: kate.lawrenson@cshs.org.
作者：
Kate,Lawrenson [1]
;
Fengju,Song [2]
;
Dennis J,Hazelett [3]
;
Siddhartha P,Kar [4]
;
Jonathan,Tyrer [4]
;
Catherine M,Phelan [5]
;
Rosario I,Corona [6]
;
Norma I,Rodríguez-Malavé [3]
;
Ji-Hei,Seo [7]
;
Emily,Adler [8]
;
Simon G,Coetzee [3]
;
Felipe,Segato [9]
;
Marcos A S,Fonseca [9]
;
Christopher I,Amos [10]
;
Michael E,Carney [11]
;
Georgia,Chenevix-Trench [12]
;
Jiyeob,Choi [13]
;
Jennifer A,Doherty [14]
;
Weihua,Jia [15]
;
Gang J,Jin [16]
;
Byoung-Gie,Kim [17]
;
Nhu D,Le [18]
;
Juyeon,Lee [19]
;
Lian,Li [2]
;
Boon K,Lim [20]
;
Noor A,Adenan [20]
;
Mika,Mizuno [21]
;
Boyoung,Park [22]
;
Celeste L,Pearce [23]
;
Kang,Shan [24]
;
Yongyong,Shi [25]
;
Xiao-Ou,Shu [26]
;
Weiva,Sieh [27]
;
Australian Ovarian Cancer Study Group [28]
;
Pamela J,Thompson [29]
;
Lynne R,Wilkens [30]
;
Qingyi,Wei [31]
;
Yin L,Woo [20]
;
Li,Yan [32]
;
Beth Y,Karlan [33]
;
Matthew L,Freedman [7]
;
Houtan,Noushmehr [34]
;
Ellen L,Goode [35]
;
Andrew,Berchuck [36]
;
Thomas A,Sellers [37]
;
Soo-Hwang,Teo [38]
;
Wei,Zheng [26]
;
Keitaro,Matsuo [39]
;
Sue,Park [13]
;
Kexin,Chen [2]
;
Paul D P,Pharoah [40]
;
Simon A,Gayther [3]
;
Marc T,Goodman [41]
作者单位：
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, USA; Center for Bioinformatics and Functional Genomics, Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: kate.lawrenson@cshs.org.
[1]
National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
[2]
Center for Bioinformatics and Functional Genomics, Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
[3]
Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
[4]
Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
[5]
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, USA; Center for Bioinformatics and Functional Genomics, Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
[6]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
[7]
Department of Preventive Medicine, University of Southern California, Keck School of Medicine, 1450 Biggy Street, Los Angeles, CA, USA.
[8]
Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, 14049-900, Brazil.
[9]
Institute for Clinical and Translational Research, Department of Medicine, Baylor School of Medicine, Houston,TX, USA.
[10]
Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
[11]
Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD 4006, Australia.
[12]
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Department of Biomedical Science, Graduate School, Seoul National University, Seoul, Republic of Korea.
[13]
Jon M. and Karen Huntsman Endowed Associate Professor in Cancer Research Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, USA.
[14]
State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong 510060, China.
[15]
ShanghaiBio Corporation, Shanghai, China; CloudHealth Genomics Ltd, Shanghai, China.
[16]
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Republic of Korea.
[17]
Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.
[18]
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Biomedical Science, Graduate School, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Republic of Korea.
[19]
The Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
[20]
Department of Gynecological Oncology, Aichi Cancer Center Hospital, Japan.
[21]
Department of Preventive Medicine, College of Medicine, Hanyang, Seoul, Republic of Korea.
[22]
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
[23]
Department of Obstetrics and Gynaecology,Hebei Medical University, Fourth Hospital, Shijiazhuang, China.
[24]
Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
[25]
Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
[26]
Department of Population Health Science and Policy, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
[27]
Peter MacCallum Cancer Institute, Melbourne, Australia.
[28]
Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
[29]
Cancer Epidemiology Program, University of Hawaii Cancer Center, HI, USA.
[30]
Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
[31]
Department of Molecular Biology, Hebei Medical University, Fourth Hospital, Shijiazhuang, China.
[32]
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, USA.
[33]
Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, 14049-900, Brazil; Department of Neurosurgery, Henry Ford Health System, Detroit, MI, USA.
[34]
Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
[35]
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
[36]
Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
[37]
Cancer Research Initiatives Foundation, Subang Jaya, Selangor, Malaysia.
[38]
Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Japan.
[39]
Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.
[40]
Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
[41]
医学主题词
碱基序列(Base Sequence);病例对照研究(Case-Control Studies);女(雌)性(Female);疾病遗传易感性(Genetic Predisposition to Disease);全基因组关联研究(Genome-Wide Association Study);人类(Humans);多态性, 单核苷酸(Polymorphism, Single Nucleotide);数量性状基因座位(Quantitative Trait Loci)
DOI
10.1016/j.ygyno.2019.02.023
PMID
30898391
发布时间
2025-04-24
- 浏览8
Gynecologic oncology
Gynecologic oncology
343-355页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
